We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+9.87%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$138B
AUM Growth
+$12B
Cap. Flow
+$443M
Cap. Flow %
0.32%
Top 10 Hldgs %
18.35%
Holding
8,009
New
285
Increased
3,874
Reduced
2,887
Closed
270

Sector Composition

Rank Sector Weight
1 Technology 6.66%
2 Financials 5.43%
3 Healthcare 5.11%
4 Consumer Discretionary 4.43%
5 Communication Services 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYCN icon
6751
Cyclerion Therapeutics
CYCN
$15.2M
$23K ﹤0.01%
425
+137
+48% +$12.8K
FGBI icon
6752
First Guaranty Bancshares
FGBI
$155M
$23K ﹤0.01%
1,137
+338
+42% +$6.04K
FLNT
6753
Fluent
FLNT
$106M
$23K ﹤0.01%
1,551
+760
+96% +$10.3K
GALT icon
6754
Galectin Therapeutics
GALT
$230M
$23K ﹤0.01%
8,029
+5,842
+267% +$20.3K
GSIT icon
6755
GSI Technology
GSIT
$201M
$23K ﹤0.01%
3,242
+2,844
+715% +$21.5K
JFR icon
6756
Nuveen Floating Rate Income Fund
JFR
$1.23B
$23K ﹤0.01%
+2,200
New +$21.1K
MTNB icon
6757
Matinas BioPharma
MTNB
$1.91M
$23K ﹤0.01%
+200
New +$11.6K
PIM
6758
Franklin Master Intermediate Income Trust
PIM
$151M
$23K ﹤0.01%
4,755
+946
+25% +$4.45K
SGA icon
6759
Saga Communications
SGA
$54.9M
$23K ﹤0.01%
761
+236
+45% +$7.17K
SPCE icon
6760
Virgin Galactic
SPCE
$315M
$23K ﹤0.01%
+100
New +$19.5K
SPRO icon
6761
Spero Therapeutics
SPRO
$68.9M
$23K ﹤0.01%
2,398
+1,108
+86% +$11.9K
SPYD icon
6762
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.76B
$23K ﹤0.01%
575
+4
+0.7% +$154
XRAY icon
6763
PUT
Dentsply Sirona
XRAY
$2.84B
$23K ﹤0.01%
400
XSW icon
6764
State Street SPDR S&P Software & Services ETF
XSW
$442M
$23K ﹤0.01%
230
IQIN
6765
DELISTED
NYLI 500 International ETF
IQIN
$23K ﹤0.01%
816
-484
-37% -$13.5K
SRLP
6766
DELISTED
SPRAGUE RESOURCES LP
SRLP
$23K ﹤0.01%
1,372
+672
+96% +$11.4K
JDD
6767
DELISTED
Nuveen Diversified Dividend and Income Fund
JDD
$23K ﹤0.01%
2,154
+100
+5% +$1.09K
ACNT icon
6768
Ascent Industries
ACNT
$139M
$22K ﹤0.01%
1,669
+529
+46% +$7.35K
AKBA icon
6769
PUT
Akebia Therapeutics
AKBA
$338M
$22K ﹤0.01%
3,478
AVXL icon
6770
Anavex Life Sciences
AVXL
$231M
$22K ﹤0.01%
8,604
+5,480
+175% +$14.4K
BH icon
6771
Biglari Holdings Class B
BH
$1.2B
$22K ﹤0.01%
193
+44
+30% +$4.49K
CHW
6772
Calamos Global Dynamic Income Fund
CHW
$516M
$22K ﹤0.01%
2,539
+63
+3% +$524
EVF
6773
Eaton Vance Senior Income Trust
EVF
$90.1M
$22K ﹤0.01%
3,415
-1,981
-37% -$12.3K
FAN icon
6774
First Trust Global Wind Energy ETF
FAN
$271M
$22K ﹤0.01%
1,508
FTK icon
6775
Flotek Industries
FTK
$789M
$22K ﹤0.01%
1,830
+537
+42% +$6.2K

Similar funds

Citigroup's Q4 2019 Portfolio in Review

As of Q4 2019, Citigroup held 8,009 positions worth $138B, up 9.5% from $126B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Citigroup's Q4 2019 filing shows 285 new, 3,874 increased, 2,887 reduced and 270 closed positions. Its largest new stake was Stanley Black & Decker, Inc.: 372,155 shares worth $40.5M. The largest sale was Celgene Corp, an estimated $749M.

By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q4 2019 buy was Stanley Black & Decker, Inc.: 372,155 shares worth $40.5M.
  • Citigroup added most to Invesco QQQ Trust in Q4 2019, an estimated $1.04B increase.
  • Citigroup's biggest Q4 2019 reduction was Alibaba, cutting an estimated $274M.
  • Citigroup fully exited Celgene Corp in Q4 2019, selling an estimated $749M.
  • Citigroup's ten largest holdings make up 18% of its $138B portfolio in Q4 2019.
  • Citigroup opened 285 new positions and closed 270 in Q4 2019.
  • Citigroup's portfolio value rose 9.5% quarter-over-quarter to $138B.

Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.